Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

Helius Medical Technologies Inc (HSM.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Helius Medical Technologies Inc 642 Newtown Yardley Road Suite 100 Newtown PA 18940 USA

P: 215-944-6100

Description:

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.

Key Statistics

Overview:

Market Capitalization, $K 42,531
Shares Outstanding, K 2,318
Annual Sales, $ 661 K
Annual Net Income, $ -14,130 K
Last Quarter Sales, $ 71 K
Last Quarter Net Income, $ -5,981 K
60-Month Beta 1.09
% of Institutional Shareholders 13.31%

Growth:

1-Year Return -6.38%
3-Year Return -95.93%
5-Year Return -92.46%

Per-Share Information:

Most Recent Earnings -2.58 on 08/12/21
Next Earnings Date N/A
Earnings Per Share ttm -8.24
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 01/04/21

HSM.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -208.02%
Return-on-Assets % -158.13%
Profit Margin % -2,137.67
Net Margin % -32.19
Debt/Equity N/A
Price/Sales 53.86
Price/Book 4.02
Book Value/Share 4.58
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar